Response Genetics Stock Net Income
| RGDXQ Stock | USD 0.0001 0.00 0.00% |
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Response Genetics, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Response Genetics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Response Genetics' valuation are summarized below:Response Genetics does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Response |
Response Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Response Genetics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Response Genetics.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Response Genetics on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Response Genetics or generate 0.0% return on investment in Response Genetics over 90 days. Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use... More
Response Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Response Genetics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Response Genetics upside and downside potential and time the market with a certain degree of confidence.
Response Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Response Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Response Genetics' standard deviation. In reality, there are many statistical measures that can use Response Genetics historical prices to predict the future Response Genetics' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Response Genetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Response Genetics Backtested Returns
We have found three technical indicators for Response Genetics, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Response Genetics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Response Genetics has perfect predictability. Overlapping area represents the amount of predictability between Response Genetics time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Response Genetics price movement. The serial correlation of 1.0 indicates that 100.0% of current Response Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Response Genetics reported net income of (20.18 Million). This is 105.91% lower than that of the Life Sciences Tools & Services sector and 111.66% lower than that of the Health Care industry. The net income for all United States stocks is 103.53% higher than that of the company.
Response Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Response Genetics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Response Genetics could also be used in its relative valuation, which is a method of valuing Response Genetics by comparing valuation metrics of similar companies.Response Genetics is currently under evaluation in net income category among its peers.
Response Fundamentals
| Return On Asset | -0.68 | |||
| Profit Margin | (0.86) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 9.24 M | |||
| Shares Outstanding | 38.8 M | |||
| Number Of Shares Shorted | 78.1 K | |||
| Revenue | 18.04 M | |||
| Gross Profit | 6.23 M | |||
| EBITDA | (19.36 M) | |||
| Net Income | (20.18 M) | |||
| Cash And Equivalents | 1.73 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 10.94 M | |||
| Current Ratio | 1.79 X | |||
| Book Value Per Share | (0.13) X | |||
| Cash Flow From Operations | (13.6 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Target Price | 1.8 | |||
| Number Of Employees | 96 | |||
| Beta | 2.09 | |||
| Market Capitalization | 116 | |||
| Total Asset | 48.88 M | |||
| Retained Earnings | (83.02 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 8.76 M | |||
| Current Liabilities | 4.88 M | |||
| Z Score | -1.4 | |||
| Net Asset | 48.88 M |
About Response Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Response Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Response Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Response Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Response Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Response Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Response Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Response Pink Sheet
The ability to find closely correlated positions to Response Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Response Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Response Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Response Genetics to buy it.
The correlation of Response Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Response Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Response Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Response Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Response Pink Sheet Analysis
When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.